Clinical Trials Study
Copyright ©2014 Baishideng Publishing Group Inc.
World J Gastroenterol. Jul 14, 2014; 20(26): 8660-8666
Published online Jul 14, 2014. doi: 10.3748/wjg.v20.i26.8660
Table 1 Comparison of clinical and laboratory parameters between the two groups before transplantation
ParameterControlBM-MNCsPvalue
Patient (n)1532ND
Age (yr)47.4 ± 11.146.4 ± 11.60.8542
Gender
Male920
Female6120.8691
HBsAg
Positive1330
Negative220.5833
Liver function
Alanine aminotransferase (IU/L)51.7 ± 14.553.2 ± 13.50.7342
Aspartate aminotransferase (IU/L)63.7 ± 14.467.9 ± 16.70.4042
Serum albumin (g/L)28.1 ± 2.827.9 ± 2.50.7962
Prealbumin (mg/L)85.1 ± 23.583.5 ± 22.40.8192
Total bilirubin (mmol/L)53.5 ± 17.952.2 ± 13.40.7722
Coagulation function
Prothrombin time (s)16.3 ± 3.016.9 ± 2.30.4372
Prothrombin activity71.8% ± 19.4%67.8% ± 15.0%0.4372
Fibrinogen (g/L)1.83 ± 0.531.81 ± 0.520.8642
Routine blood indices
White blood cell counts (× 109/L)2.83 ± 1.072.73 ± 0.840.7212
Hemoglobin (g/L)107.8 ± 11.4105.9 ± 12.60.6242
Platelet counts (× 109/L)69.0 ± 16.667.2 ± 15.50.7172
Table 2 Comparison of the occurrence of complications between the two groups
Patient groupnEsophageal variceal hemorrhageHepatic encephalopathySpontaneous bacterial peritonitisHepatocellular carcinoma
Control152331
BM-MNCs321001
P value0.23510.02810.02810.5411
Table 3 Levels of albumin, prealbumin and total bilirubin in the two groups at different time points after transplantation
Liver functionGroup1 wk1 mo3 mo6 mo12 mo24 mo
Serum albumin (g/L)1Control29.2 ± 2.529.8 ± 2.830.3 ± 2.230.4 ± 3.329.7 ± 4.328.8 ± 3.4
BM-MNCs28.4 ± 2.730.2 ± 3.233.5 ± 3.633.9 ± 3.534.5 ± 4.230.7 ± 3.8
P value0.3570.6690.0020.0020.0010.096
Prealbumin (mg/L)1Control92.5 ± 25.9101.4 ± 28.7111.1 ± 27.7113.6 ± 26.5115.0 ± 23.997.4 ± 17.7
BM-MNCs91.1 ± 23.2118.3 ± 25.3139.8 ± 25.9138.1 ± 24.6139.9 ± 25.3107.9 ± 22.7
P value0.860.0470.0010.0030.0030.122
Total bilirubin (mmol/L)1Control51.3 ± 15.647.3 ± 16.545.6 ± 19.943.0 ± 20.838.7 ± 16.636.6 ± 14.2
BM-MNCs50.9 ± 12.644.2 ± 13.536.9 ± 9.732.2 ± 10.629.3 ± 9.732.7 ± 10.7
P value0.920.4960.0480.0220.0180.294
Table 4 Levels of prothrombin time, prothrombin activity and fibrinogen in the two groups at different time points after transplantation
FunctionGroup1 wk1 mo3 mo6 mo12 mo24 mo
Prothrombin time (s)1Control16.2 ± 2.816.3 ± 2.815.9 ± 2.815.7 ± 2.915.5 ± 2.915.7 ± 2.3
BM-MNCs16.8 ± 2.515.5 ± 2.514.4 ± 2.313.9 ± 2.114.0 ± 2.114.4 ± 2.1
P value0.4720.3110.0460.0190.0510.06
Prothrombin activity1Control72.5% ± 17.8%72.0% ± 17.7%74.4% ± 17.8%75.9% ± 18.2%77.4%± 18.2%75.6% ± 14.6%
BM-MNCs68.7% ± 16.0%77.3% ± 15.7%84.3% ± 14.3%87.2% ± 13.3%86.9% ± 13.5%84.0% ± 13.6%
P value0.4720.3110.0460.0190.0510.06
Fibrinogen (g/L)1Control1.90 ± 0.581.92 ± 0.571.89 ± 0.441.97 ± 0.401.99 ± 0.391.93 ± 0.28
BM-MNCs1.86 ± 0.552.12 ± 0.642.28 ± 0.532.51 ± 0.552.49 ± 0.512.11 ± 0.52
P value0.8570.2890.0170.0010.0020.233
Table 5 Levels of white blood cell counts, hemoglobin, and platelet counts in the two groups at different time points after transplantation
Routine blood indicesGroup1 wk1 mo3 mo6 mo12 mo24 mo
White blood cell counts (× 109/L)1Control2.82 ± 0.982.88 ± 0.952.85 ± 0.942.78 ± 0.962.69 ± 1.002.63 ± 0.92
BM-MNCs2.69 ± 0.802.96 ± 0.743.23 ± 0.803.44 ± 0.793.22 ± 0.772.94 ± 0.72
P value0.6380.750.1590.0170.0520.208
Hemoglobin (g/L)1Control108.7 ± 12.5110.7 ± 13.3112.8 ± 15.9113.3 ± 15.2114.5 ± 18.1106.8 ± 14.3
BM-MNCs106.3 ± 12.5112.4 ± 13.2121.8 ± 12.0124.1 ± 12.8120.4 ± 11.9110.8 ± 16.8
P value0.5520.6880.0360.0140.1930.432
Platelet counts (× 109/L)1Control68.9 ± 13.266.7 ± 13.863.3 ± 15.763.1 ± 13.962.1 ± 16.461.2 ± 15.6
BM-MNCs69.3 ± 16.170.1 ± 13.774.5 ± 15.775.8 ± 11.674.8 ± 14.767.7 ± 15.2
P value0.9360.3490.0270.0020.0110.185